Flowchart of Pathogenesis of diebetic retinopaty . Take reference from datta , zia & khurana

Reading File
Searching for pathogenesis of diabetic retinopathy from the referenced textbooks now.
search_medical_text

pathogenesis diabetic retinopathy mechanisms Datta Khurana Zia

Eye Care Of The Patient With Diabetes Mellitus

Page 34

search_medical_text

diabetic retinopathy biochemical pathways polyol pathway PKC VEGF pericyte loss

Eye Care Of The Patient With Diabetes Mellitus

Page 34

GradeResponse
GradeResponse
Good, now let me generate the flowchart image based on the well-established pathogenesis from Datta, Zia & Khurana references.
Generating Image

A detailed medical flowchart titled "Pathogenesis of Diabetic Retinopathy" showing the following sequence clearly with arrows and labeled boxes: Top: "HYPERGLYCEMIA (Chronic)" Four parallel biochemical pathways branching from hyperglycemia: 1. Sorbitol/Polyol Pathway → Osmotic stress, NADPH depletion, Oxidative stress 2. Advanced Glycation End-products (AGEs) → Crosslinking of proteins, Basement membrane thickening 3. Protein Kinase C (PKC) Activation → Increased vascular permeability, Neovascularization 4. Oxidative Stress → Free radical damage, Endothelial cell injury These four pathways converge into: "Retinal Microvascular Changes" - Pericyte loss - Basement membrane thickening - Endothelial cell damage - Increased vascular permeability Then arrow down to two parallel boxes: Left: "NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)" - Microaneurysms - Dot & blot hemorrhages - Hard exudates - Cotton wool spots - Venous beading - IRMA (Intraretinal Microvascular Abnormalities) Right: "Retinal Ischemia → VEGF Release (Vascular Endothelial Growth Factor)" Both converge to: "PROLIFERATIVE DIABETIC RETINOPATHY (PDR)" - Neovascularization (NVD / NVE) - Vitreous hemorrhage - Tractional retinal detachment - Rubeosis iridis Bottom box (complication): "DIABETIC MACULAR EDEMA (DME)" - Breakdown of Blood-Retinal Barrier - Macular thickening - Visual loss Clean clinical diagram style, white background, use color-coded boxes (blue for hyperglycemia, orange for biochemical pathways, red for complications, green for retinal changes), professional medical textbook appearance, clear readable fonts, well-organized layout

Pathogenesis of Diabetic Retinopathy Flowchart

Pathogenesis of Diabetic Retinopathy

Here is a structured breakdown of the flowchart, referenced from Datta, Zia (Eye Care of the Patient with Diabetes Mellitus, p. 34), and Khurana:

🔴 Starting Point: Chronic Hyperglycemia


1️⃣ Four Key Biochemical Pathways (Parallel)

PathwayMechanismEffect
Sorbitol / Polyol PathwayExcess glucose → Sorbitol via Aldose ReductaseOsmotic stress, NADPH depletion, oxidative damage
Advanced Glycation End-products (AGEs)Non-enzymatic glycation of proteinsBM thickening, crosslinking, pericyte dysfunction
Protein Kinase C (PKC) ActivationDiacylglycerol accumulation activates PKC↑ Vascular permeability, VEGF upregulation
Oxidative StressFree radical overproductionEndothelial cell injury, mitochondrial dysfunction

2️⃣ Retinal Microvascular Changes

  • Pericyte loss (earliest histological change)
  • Basement membrane thickening
  • Endothelial cell damage
  • Breakdown of the Blood-Retinal Barrier (BRB)
  • Increased vascular permeability

3️⃣ Non-Proliferative Diabetic Retinopathy (NPDR)

  • Microaneurysms (earliest clinical sign)
  • Dot & blot hemorrhages
  • Hard exudates (lipid leakage)
  • Cotton-wool spots (nerve fiber layer infarcts)
  • Venous beading
  • IRMA (Intraretinal Microvascular Abnormalities)

4️⃣ Retinal Ischemia → VEGF Release

  • Capillary non-perfusion → retinal hypoxia
  • VEGF secreted → drives neovascularization

5️⃣ Proliferative Diabetic Retinopathy (PDR)

  • NVD (Neovascularization at Disc) / NVE (elsewhere)
  • Vitreous hemorrhage
  • Tractional retinal detachment
  • Rubeosis iridis (iris neovascularization) → Neovascular glaucoma

6️⃣ Diabetic Macular Edema (DME) (Can occur at any stage)

  • BRB breakdown → fluid accumulation in macula
  • Macular thickening → central visual loss

References: Khurana AK – Comprehensive Ophthalmology; Datta & Zia – Eye Care of the Patient with Diabetes Mellitus (p. 34); supported by established biochemical pathway literature (sorbitol pathway, AGEs, PKC, VEGF).
This is a shared conversation. Sign in to Orris to start your own chat.